Ocular immune privilege: therapeutic opportunities from an experiment of nature
The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the vitreous space, there are higher chances of exposure to systemic circulation,15 whereas the subretinal space does not expose AAV to systemic circulation, owing to the blood-retina barrier.9,33”
From Systemic and local immune responses to intraocular AAV vector administration in non-human primates (2022) · cites this paper as [9]
In the citing paper
“Idebenone (Raxone), a synthetic analogue of coenzyme Q10, has been used by practitioners in the European Union albeit with controversial efficacy, because results from a phase 3 study were not statistically different from placebo.11”
In the citing paper
“The eye was historically considered to be an immune privileged site, as a result of several features. These include the blood-retinal barrier formed by tight junctions between endothelial and retinal pigmented epithelium cells as well as in retinal vessels, the lack of anatomically defined lymphatic drainage and an intraocular anti-inflammatory and immunomodulatory micro-environment [43].”
From Characterization of anti-AAV2 neutralizing antibody levels in sheep prior to and following intravitreal AAV2.7m8 injection (2024) · cites this paper as [43]
In the citing paper
“Additionally, there are lower risks of immunogenicity when targeting AAV vectors towards relatively immune-privileged sites, such as the subretinal space and the cochlea [93,94].”
From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [93]
Citations
Cites
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
BackgroundMedawar, P. B. (1948) · PubMed · Cited by 1,109
Immunologically Privileged Sites
Barker, C. F., & Billingham, R. E. (1978) · Advances in Immunology · doi:10.1016/s0065-2776(08)60930-x · Cited by 815
PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
Carter, L. L., Fouser, L. A., Jussif, J., Fitz, L., Deng, B., Wood, C. R., Collins, M., Honjo, T., Freeman, G. J., & Carreno, B. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<634::aid-immu634>3.0.co;2-9 · Cited by 673
Immunobiology of Tissue Transplantation: A Return to the Passenger Leukocyte Concept
Laffery, K. J., Prowse, S. J., Simeonovic, C. J., & Warren, H. S. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.001043 · Cited by 509
Suda, T., Hashimoto, H., Tanaka, M., Ochi, T., & Nagata, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2045 · Cited by 508 · cited 1×
“Attempts to achieve this goal with CD95L have already been made and the results are mixe”
ResultIdentification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor.
Cousins, S. W., McCabe, M. M., Danielpour, D., & Streilein, J. W. (1991) · PubMed · Cited by 477
Self-citationKang, S.-M., Schneider, D. B., Lin, Z., Hanahan, D., Dichek, D. A., Stock, P. G., & Baekkeskov, S. (1997) · Nature Medicine · doi:10.1038/nm0797-738 · Cited by 450 · cited 1×
“First, conventional immune-recognition pathways can be interrupted by providing allografts with healthy corneal epithelium, or factors derived from this tissue that suppress lymphangiogenesis and attendant inflammatio”
BackgroundSo, K.-F., & Aguayo, A. J. (1985) · Brain Research · doi:10.1016/0006-8993(85)91047-9 · Cited by 390
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J., Yu, X., & Ferguson, T. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119173 · Cited by 367 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
Background
Research works printed but not linked: 5
- Haskova, Z., Arancibia-Carcamo, C. V., Christianson, G. J., Roopenian, D. C. & Ksander, B. R. in Uveitis in the Third Millenium (eds Dodds, E. M. & Couto, C. A.) 7–10 (Elsevier Science, Amsterdam, 2000).
- Sano, Y., Ksander, B. R. & Streilein, J. W. Fate of orthotopic corneal allografts in eyes that cannot support ACAID induction. Invest. Ophthalmol. Vis. Sci. 36, 2176–2185 (1995). This paper shows how immune privilege in the eye is disrupted by experimental manipulations of the cornea.
- Bora, H. S. et al. in Advances in Ocular Imunolology (eds Nussenblatt, R. B., Whitcup, S. M., Caspi, R. R. & Gery, I.) 83–86 (Amsterdam, Elsevier, 1994).
- Hori, J. & Streilein, J. W. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Invest. Ophthalmol. Vis. Sci. 42, 720–726 (2001).
- Ishida, K., Panjwani, N., Cao, Z. & Streilein, J. W. Participation of pigment epithelium in ocular immune privilege. 3. Galectin-1 contributes to immunosuppressive properties of retinal pigment epithelium. Ocular Immun. Inflamm. (in the press).
Cited by
Items 701–800 of 806
Ca2+ Channels in the Retinal Pigment Epithelium
Strauß, O. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-375-2_11
Induction of Immunological Tolerance to Transgene Products
Sack, B. K., Markusic, D. M., & Herzog, R. W. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5480-9_15
Molecular and cellular mechanisms of heart regeneration in zebrafish
Ronquillo, E. S. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Jiang, X. (2012) · Human Biology
Antiangiogenic Treatment Options in the Cornea
Cursiefen, C., & Bock, F. (2012) · Springer eBooks · doi:10.1007/978-3-642-28747-3_5
“This so-called “angiogenic privilege” [ 1, 3, 4 ] is not only essential for good visual acuity but also is responsible for the excellent survival of corneal grafts placed into avascular low-risk recipient beds since in these eyes the graft is physically separated both from the afferent (lymphatic) as well as the effer…”
BackgroundResultInfluentialCellular immune responses to low density lipoprotein in atherosclerosis
Hermansson, A. (2010) · Figshare
Черешнев, В. А., Shilov, Y. I., Владимировна, Ч. М., Medvedeva, S. Y., Крохина, Н. Б., Shilov, S. Y., & Gavrilova, T. V. (2012) · Doklady Biological Sciences · doi:10.1134/s0012496612020123
The End of an Era: Wayne Streilein and His Impact on Transplantation Immunology
Burlingham, W. J. (2004) · Transplantation · doi:10.1097/01.tp.0000135954.48021.6f
Transplantation of Marrow Stromal Cells into the Developing Mammal Retina
Lee, E.-S., Kwon, O.-J., Ye, E., & Jeon, C. (2013) · Journal of Korean Ophthalmic Optics Society · doi:10.14479/jkoos.2013.18.4.541
“망막은 복잡한 외과적 수술 없이 유리체를 통한 접 근이 용이하며, 눈의 면역회피기능(immune privilege)은 이식된 세포의 거부 반응을 감소시킨다.([3]) 이 때문에 망막 은 중추신경계의 발달(development), 가소성(plasticity), 그 리고 재생(regeneration) 연구와 줄기세포의 연구에 이상적 인 실험 모델로서의 역할을 수행할 수 있다.”
Clinical images: Joint involvement in idiopathic arterial calcification of infancy
Feraco, P., Bazzocchi, A., & Scioscio, V. D. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24529
Черешнев, В. А., Fayzrakhmanov, R. R., Gavrilova, T. V., Владимировна, Ч. М., Shilov, Y. I., & Rodionov, S. Y. (2007) · Doklady Biological Sciences · doi:10.1134/s0012496607060026
Rare anterior uveitis entities
Kuebler, A. G. (2014) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.16708
Review of approaches to cell therapy in ophthalmology
Суббот, А. М., & Kasparova, E. A. (2015) · Russian Annals of Ophthalmology · doi:10.17116/oftalma2015131574-81 · Cited by 1
PROGRAMA DE PÓS-GRADUAÇÃO EM GENÉTICA
Sonehara, N. M. (2013)
Antifungal ocular drug delivery via contact lenses using a novel in vitro eye model
Phan, C. (2016) · UWSpace (University of Waterloo)
Corjon, S. (2008) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-1481
Animal Models of Age-Related Macular Degeneration: Subretinal Inflammation
Sennlaub, F. (2015) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-3-319-19434-9_4
An experimental autoimmune uveoretinitis model and intraocular inflammation
Li, J., & Chu, W.-K. (2016) · Hong Kong Journal of Ophthalmology · doi:10.12809/hkjo-v20n1-193 · Cited by 3
Dana, R., & Foster, C. S. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0016-7.50008-4
Antigen Presenting Cell Interactions with Cells During Anterior Chamber Associated Immune Deviation
Stein-Streilein, J. (2007) · CRC Press eBooks · doi:10.3109/9781420020342-7
Penetrating and Endothelial Keratoplasty: An Overview
Maharana, P. K., Pattebahadur, R., & Sharma, N. (2016) · Springer eBooks · doi:10.1007/978-81-322-2818-9_3
CD8+ T Regulatory Cells in Eye Derive Tolerance
Stein‐Streilein, J., & Keino, H. (2008) · Springer eBooks · doi:10.1007/978-0-387-77909-6_25
“immune privilege of the eye is best studied with an animal model called ACAID [11,12].”
BackgroundInfluentialCastellar, L. D. S. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2015.tde-12062015-161511
Gentherapie zur Behandlung von Netzhauterkrankungen
Ochakovski, G. A., Bartz‐Schmidt, K. U., & Fischer, M. D. (2017) · Medizinische Genetik · doi:10.1007/s11825-017-0133-7
“Da die Gentherapie derzeit auf rekombinantenAAV-Virenbasiert, besteht die Möglichkeit, dass die angeborenen und erworbenen antiviralen Immunmechanismen des Körpers auch gegen gentherapeutische Vektoren aktiv werden [16].”
Neurotropism of Theiler's murine encephalomyelitis virus
Villarreal, D. (2005) · OakTrust (Texas A&M University Libraries)
Kozariichuk, N. Y. (2018) · Clinical & experimental pathology · doi:10.24061/1727-4338.xv.2.56.2016.46
Lafosse, E. (2019) · Aston Publications Explorer (Aston University) · doi:10.48780/publications.aston.ac.uk.00041160
Jager, M. J., Dennaoui, J., & Maat, W. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3167-3.50009-7
ANÁLISE DE DIFERENTES MÉTODOS NO DIAGNÓSTICO DA COVID-19: UMA REVISÃO DE LITERATURA
de Santana, K. S. L., Souza, S. H. V. V., Souza, S. H. V. V., de Santana, G. S. L., de Jesus, B. B. D. S., Neto, M. N. B., de Carvalho, M. D. J. D. S., de Freitas, K. N. P., de Oliveira, V. J. D. S., & de Almeida, W. A. B. (2020) · doi:10.22533/at.ed.6892026103
COVID-19 E SAÚDE OCULAR: UMA REVISÃO DA LITERATURA
Oliveira, J. R. A., & Arraes, D. C. D. (2020) · doi:10.22533/at.ed.6892026108
Ocular Blast Trauma: Mechanisms of Degeneration and a Potential Therapeutic Strategy
Bricker-Anthony, C. (2016) · Cited by 1
The Role of Pyroptosis and Associated Inflammasomes during Experimental Cytomegalovirus Retinitis
Carter, J. (2020) · Digital Archive @ GSU · doi:10.57709/20370936
The ultimate terminus of evolutional symbiosis leaves a flaw: blinding herpetic stromal keratitis
Hayashi, K. (2020) · New Frontiers in Ophthalmology · doi:10.15761/nfo.1000252
“The eye is an immunologically privileged site [16].”
Mesenchymal stem cells for therapeutic application in corneal transplantation
Treacy, O. (2014) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/17328
...Y la danza se hizo cuerpo: entrevista a Ryotaro Fujima
Lucas, F. C. (2014) · ADE teatro: Revista de la Asociación de Directores de Escena de España
Maleki, A., Drenen, K., & Foster, C. S. (2021) · Springer eBooks · doi:10.1007/978-3-319-90495-5_329-2
Reviews and comment from the nature publishing group
(2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1242
Kyewski, B. (2006) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1051541.503445
Pradeu, T. (2010) · Les Presses de l'Université de Montréal eBooks · doi:10.4000/books.pum.2242
Trofimova, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-50160-0_1
Regulation of Immune Responses
Maleki, A., Manhapra, A., Mousa, H. M., & Foster, C. S. (2021) · Springer eBooks · doi:10.1007/978-3-319-90495-5_332-1
Maleki, A., Drenen, K., & Foster, C. S. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_329
Regulation of Immune Responses
Maleki, A., Manhapra, A., Mousa, H. M., & Foster, C. S. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_332
Jager, M. J., & Bronkhorst, I. H. G. (2019) · Springer eBooks · doi:10.1007/978-3-030-04489-3_6
Gelder, R. N. V. (2005) · Ocular Immunology and Inflammation · doi:10.1080/09273940590909130
Maleki, A., Drenen, K., & Foster, C. S. (2021) · Springer eBooks · doi:10.1007/978-3-319-90495-5_329-1
Antigen Presenting Cell Interactions with Cells During Anterior Chamber Associated Immune Deviation
Stein‐Streilein, J. (2007) · CRC Press eBooks · doi:10.3109/9781420020342-4
Autoimmune Diseases and Retina
Pangal, E., ÖZSAYGILI, C., & BAYRAM, N. (2022) · Güncel Retina Dergisi (Current Retina Journal) · doi:10.37783/crj-0349
Effect of Intra-Stromal Bevacizumab on Corneal Vascularization
Niazi, M. K., Masood, H., Ali, K., Malik, S. M., & Arshad, M. A. (2022) · Pakistan Journal of Ophthalmology · doi:10.36351/pjo.v39i1.1550
Sun, M. M., & Gordon, L. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8165-1.00074-5
Stem cell-based organoid cultures as innovative approaches for ocular repair and regeneration
Nasonkin, I. O., & Rizzolo, L. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99987-8.00005-9
Looking beyond Self-Protection: The Eyes Instruct Systemic Immune Tolerance Early in Life
Villafán, H., & Gutiérrez‐Ospina, G. (2023) · Brain Sciences · doi:10.3390/brainsci13091261
Role of Stem Cells in the Delivery of Essential Pharmaceuticals
Rafiq, A., Jan, I., Ali, M., Aashaq, S., Reshi, B. A., Shah, Z. A., Sheikh, F. A., Majeed, S., & Beigh, M. A. (2023) · Springer eBooks · doi:10.1007/978-981-99-2119-5_29
Immune System Influence on Hematopoietic Stem Cells and Leukemia Development
Perry, J. M. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-7471-9_8
Unconventional Aqueous Humor Outflow
Huang, A. S., & Johnson, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13820-1.00122-5
Betancor, P. K., Böhringer, D., Maier, P. C., Lapp, T., & Reinhard, T. (2024) · Interactive Journal of Medical Research · doi:10.2196/50106
“Animal models theorize that the spleen is essential in the induction of ACAID [13,14]; evidence to support this theory does not exist from clinical studies.”
BackgroundConcept of Angiogenic Privilege
Clahsen, T., & Cursiefen, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13820-1.00159-6
Fang, F., Wang, Y., Xiao, Y., Li, H., & Tian, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39211
Jager, M. J., Ma, S., Pinos, E. D. L., & Bronkhorst, I. H. G. (2025) · Springer eBooks · doi:10.1007/978-3-031-75907-9_7
Feng, Y., & Dana, R. (2025) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000571
Lee, S.-J., Narimatsu, A., Heydarian, N., Krauthammer, M., Bhullar, S., Chen, Y., Chauhan, S. K., Dohlman, T. H., & Dana, R. (2025) · Transplant Immunology · doi:10.1016/j.trim.2025.102284
Li, Z. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110705
L' immunologie et la définition de l'identité biologique
Pradeu, T. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 8
Jager, M. J., Dennaoui, J., & Maat, W. (2009) · Elsevier eBooks · doi:10.1016/b978-84-8086-369-8.50004-3
Alfaar, A. S., Stürzbecher, L., Diedrichs‐Möhring, M., Lam, M., Roubeix, C., Ritter, J., Schumann, K., Annamalai, B., Pompös, I.-M., Rohrer, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21384335
Ru, L., Wu, N., Wei, K., Zeng, Y., Li, Q., Weng, C., Ren, C., Ren, B., Huo, D., Li, Y., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13290500
Mohan, K. V., Mishra, A., Muniyasamy, A., Sinha, P., Sahu, P., Kesarwani, A., Jain, K., Nagarajan, P., Scaria, V., Agarwal, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21351416
Niederkorn, J. Y., & Ligocki, A. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00516-0
Meshko, B., Volatier, T. L. A., Cursiefen, C., & Notara, M. (2026) · Cells · doi:10.3390/cells15010091 · Cited by 3
“The cornea maintains its immune privilege through a combination of active and passive mechanisms that act across the three darts of an immune reflex arc [141,142].”
Chen, B., Foo, C., Andersson, A., Kayser, B. D., Yang, Y., Missarova, A., Kulkarni, P., Huetter, J.-C., Chatterjee, S., Kim, Y. J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.16.697961 · Cited by 1
Cell and Gene Therapy in Equine Ocular Disease
Young, K. A. S., Schnabel, L. V., & Gilger, B. C. (2026) · Veterinary Ophthalmology · doi:10.1111/vop.70151
“Ocular relative immune-privilege shields some of the concern for immune response to foreign antigens [100, 101].”
Topical mycophenolate for the treatment of uveitis-associated inflammation
Chauhan, J., Gherardi, E., Jang, H. L., & Sengupta, S. (2026) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-026-00569-y
“The immune-privileged state of eye [13] is broken in uveitis and an inflammatory process develops characterized by intraocular infiltration of leukocytes [14].”
Tseng, A. M., Kandoi, S., Heur, M., & Lee, S. Y. (2026) · Current Eye Research · doi:10.1080/02713683.2026.2631583
Bai, J., Wu, Z., Wan, Z., Zhao, C., Liu, Y., & Wang, T. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2026.101457
Smart contact lenses unlocking non-invasive eye treatment
Liu, M., Gan, X., Yao, G., & Lin, Y. (2026) · Fundamental Research · doi:10.1016/j.fmre.2026.03.010
“The anterior segment, comprising the cornea, anterior chamber, and lens along with its suspensory ligaments, is the primary site for most ocular pathologies [ 11 ] ( Fig.”
Ciarrochi, E., & Ciarrochi, J. B. (2026) · Journal of Ophthalmology and Advance Research · doi:10.46889/joar.2026.7113
Biomarqueurs rétiniens de la maladie d'Alzheimer et du vieillissement cérébral
Gomez, J. L. M. (2016) · theses.fr (ABES) · doi:10.70675/477e6a1ez209az4a71za0c6z8629c2d7e785
Touhami, S. (2018) · theses.fr (ABES) · doi:10.70675/906d91bcz2fb6z4a41zb6bez8e9eff5bb35b
Rabesandratana, O. (2019) · theses.fr (ABES) · doi:10.70675/90803044zeb76z4ef0z9d5bz38e212c54762 · Cited by 1
Proof of principle of therapies for dominant optic atrophy type1
Gurram, V. (2020) · theses.fr (ABES) · doi:10.70675/8e22a535zaa4az436bz9cf4z11d1971241f5
Rôle du facteur H du complément et du récepteur CD47 dans l’inflammation sous-rétinienne
Augustin, S. (2021) · theses.fr (ABES) · doi:10.70675/be8ffdbez2125z4378za1bbzb8ba72c35267
Study of development and regeneration of corneal innervation in transgenic mice
Bizzarri, E. (2024) · theses.fr (ABES) · doi:10.70675/4c0aeb72z4db4z48b0z8ba2zf8fe68767fe2
Anterior chamber inflammation grading with automatized image processing software
Aydoğdu, H. İ., & Yalçındağ, F. N. (2026) · Scientific Reports · doi:10.1038/s41598-026-49141-7
Structure and function of the retinal pigment epithelium
Strauß, O., & Wildner, G. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-22193-4.00020-2
Lee, M., Wang, B., Wang, K., Okada, K., Flanders, J. A., Barutis, A., Melero‐Martin, J. M., & Ma, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.03.730028
Pingali, T., Sethu, S., Kommana, S., Singh, S., Shanbhag, S. S., Ghosh, A., Basu, S., & Singh, V. M. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.6.26
“11 Evolutionarily, the eye has been proposed as an immune-privileged site, characterized by its ability to prolong the survival of allogenic tissue that would typically undergo rapid rejection in other sites.”
Ueta, M. (2026) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2026.2691029
“It must maintain transparency for vision while continuously exposed to environmental pathogens and antigens [1,8,9].”
Schlecht, A., Müllerbauer, L., Fitz, K., Brunne, B., Hofmann, N., Müller, C., Hillenkamp, J., Ergün, S., Neueder, A., & Braunger, B. M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1813788
When Macrophages Heal and When They Scar: Timing in Corneal Fibrosis
Yaghmour, A., Arabpour, Z., Al-Khudari, H., & Djalilian, A. R. (2026) · Life · doi:10.3390/life16071090 · Cited by 2
“This immune-privileged status is actively sustained by tightly regulated cellular and molecular mechanisms that balance immune surveillance with controlled inflammatory responses [6].”
Li, X., Qin, W., Long, H., & Chen, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1884073
“Current studies (6 – 9) suggest that the predilection of Toxoplasma gondii lesions for the posterior pole retina, especially the macular region, is related to several mechanisms.”
RNA delivery to the corneal endothelium using charge-altering releasable transporters
Wang, S. K., Li, Z., Shah, S. H., Edwards, Q. A., Bouffard, R., Hines, E. S., Imventarza, J. A., Korte, S., Lawrence, M. S., Song, E., et al. (2026) · Science Advances · doi:10.1126/sciadv.ady8161
“The eye is an attractive target for RNA medicines due to its accessible anatomy, small size, compartmentalized structure, and relative immune tolerance ( 20 , 21 ).”
Viggiano, P., Pignataro, M. G., Termite, A. C., Boscia, G., Savastano, A., Evangelista, F., Alessio, G., Boscia, F., Pető, T., & Chakravarthy, U. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101512
Wang, Y., Wang, Z., Zhou, F., Qiao, Y., Luo, Z., Wang, F., Yue, B., & Xin, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1946857 · Cited by 2
Metadata
- Authors
- Streilein, J. W.
- Affiliations
- Harvard University (US)
- Corresponding author
- Streilein, J. Wayne
- Venue
- Nature Reviews Immunology
- Published
- 2003-11
- Volume
- 3
- Issue
- 11
- Pages
- 879-889
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2166550261
- Cited by
- 807
- References
- 125
- Citations by year
- 2026: 33 · 2025: 33 · 2024: 40 · 2023: 31 · 2022: 43 · 2021: 54 · 2020: 46 · 2019: 31 · 2018: 33 · 2017: 44 · 2016: 39 · 2015: 34 · 2014: 28 · 2013: 31 · 2012: 37
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Keywords
- ocular immune privilege, eye, intraocular inflammation, vision loss, autoimmune eye disease, corneal transplantation, allograft acceptance, corneal immunology
- MeSH terms
- Animals, Autoimmune Diseases, Eye, Eye Diseases, Humans, Immunity, Inflammation, Transplantation, Homologous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.